Business Context and Reporting Period
Company: Spatializer Audio Laboratories, Inc. (Note: Request metadata listed "Enveric Biosciences," but the filing text identifies the registrant as Spatializer Audio Laboratories, Inc.)
Period: Quarterly report (Form 10-Q) for the period ended June 30, 2008.
Status: The Company is a "shell company" with no active commercial operations. It sold substantially all of its operating assets and intellectual property to DTS, Inc. on July 2, 2007. Following a nine-month indemnification period, the Company distributed remaining cash assets to shareholders in April 2008. A new investor group took control of management in April 2008.
Key Financial Metrics
| Metric | Q2 2008 (3 Months) | Q2 2007 (3 Months) | YTD 2008 (6 Months) | YTD 2007 (6 Months) |
|---|---|---|---|---|
| Revenues | $0 | $360,914 | $0 | $720,599 |
| Operating Expenses | $37,999 | $182,735 | $108,681 | $280,310 |
| Net Income (Loss) | $(36,484) | $149,768 | $(100,875) | $383,426 |
| Cash and Equivalents (End of Period) | $95,586 | $726,276 | $95,586 | $726,276 |
| Working Capital | $91,230 | $1,557,105 | $91,230 | $1,557,105 |
| Debt | $0 | $9,680 | $0 | $9,680 |
Liquidity: Cash decreased significantly from $582,019 at year-end 2007 to $95,586 at June 30, 2008, primarily due to a $1,365,000 cash distribution to shareholders in April 2008 and the liquidation of $1,000,000 in short-term investments to fund that distribution.
Material Changes vs. Prior Period
- Revenue Cessation: Revenues dropped 100% to $0 compared to the prior year periods. The Company ceased commercial operations in 2006 and sold all operating assets in July 2007. There are no current sources of revenue.
- Profitability Shift: The Company reported a net loss of $36,484 for Q2 2008, compared to a net profit of $149,768 in Q2 2007. The loss is attributed to general and administrative expenses required to maintain the corporate shell.
- Expense Reduction: Operating expenses decreased significantly ($37,999 in Q2 2008 vs. $182,735 in Q2 2007) due to the suspension of sales, marketing, and R&D activities.
- Capital Structure: The Company paid off its note payable of $9,680 in March 2008. No new debt was incurred.
Outlook, Risks, and Management Commentary
- Going Concern: The filing explicitly states that the Company's circumstances raise substantial doubt about its ability to continue as a going concern. It has no current source of future cash flow.
- Future Operations: Management states there is no assurance that a new business model or outside funding will be secured. The new investor group (controlling shareholders as of April 2008) may propose a new direction, but no specific plan is detailed.
- Internal Controls: The Company identified a material weakness in internal controls due to limited segregation of duties, as only one part-time employee and a contract bookkeeper remained to manage accounting records.
- Subsequent Events: The Board declared a 1-for-10 reverse stock split to be implemented as soon as practicable. A change of control occurred in April 2008 with the resignation of previous directors and the appointment of new management.
- Tax Assets: The Company holds approximately $26 million in net operating loss carry-forwards, but due to the change of control, these are expected to be limited or unusable for future taxable income.
Investor Verification Checklist
- Asset Sale Finality: Verify that the sale of assets to DTS, Inc. is fully closed and that no contingent liabilities or indemnification claims remain outstanding.
- New Business Plan: Confirm if the new management team has secured funding or identified a specific new business model to replace the sold audio technology assets.
- Reverse Stock Split: Monitor the implementation status of the declared 1-for-10 reverse stock split and its impact on share liquidity.
- Cash Runway: Assess the sufficiency of the remaining $95,586 cash balance to cover ongoing administrative costs without immediate dilution or additional financing.
- Legal Proceedings: Review for any undisclosed litigation related to the asset sale or the change of control that could impact the residual cash.